<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have shown that antiphospholipid (aPL) enhances expression of intercellular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (ICAM-1), vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (VCAM-1), and E-selectin on endothelial cells (ECs) and that these effects are correlated with increased <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of leukocytes to endothelium in cremaster muscle in vivo and with <z:mp ids='MP_0005048'>thrombosis</z:mp> in a mouse model </plain></SENT>
<SENT sid="1" pm="."><plain>Activation of ECs by aPL may create a <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> that precedes and contributes to <z:mp ids='MP_0005048'>thrombosis</z:mp> in patients with aPL syndrome (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>This study proposed to examine whether this in vivo activation of ECs and enhanced <z:mp ids='MP_0005048'>thrombosis</z:mp> by aPL are mediated by ICAM-1, P-selectin, or VCAM-1 </plain></SENT>
<SENT sid="3" pm="."><plain>The dynamics of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and the number of adhering leukocytes were studied in ICAM-1-deficient (ICAM-1(-/-)) mice or ICAM-1-/P-selectin-deficient (ICAM-1(-/-)/P-selectin(-/-)) mice treated with affinity-purified aPL antibodies (ap IgG-APS) or with control IgG and compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice treated in a similar fashion </plain></SENT>
<SENT sid="4" pm="."><plain>In another set of experiments, the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of leukocytes to cremaster muscle and the dynamics of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation were studied in CD1 mice treated with aPL or control IgG before and 30 minutes after intravenous infusion with 100 microg monoclonal antibody anti-VCAM-1 </plain></SENT>
<SENT sid="5" pm="."><plain>The results indicate that the enhanced <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of leukocytes to endothelium in <z:mp ids='MP_0002169'>wild-type</z:mp> mice was significantly reduced in ICAM-1(-/-) and completely abrogated in ICAM-1(-/-)/P-selectin(-/-) mice treated with ap IgG-APS compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice treated with ap IgG-APS (6.9+/-2.3, 0.4+/-0.4 versus 35+/-12, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>More importantly, this correlated with a significant reduction in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> size compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice treated with ap IgG-APS (895+/-259 microm(2), 859+/-243 microm(2) versus 3816+/-672 microm(2), respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Infusion of the mice with anti-VCAM-1 antibodies significantly reversed the enhanced <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of leukocytes (14.9+/-3 to 11.3+/-2.1) and <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> size 3830+/-1008 microm(2) versus 876+/-548 microm(2)) in mice treated with ap IgG-APS </plain></SENT>
<SENT sid="8" pm="."><plain>The data indicate that ICAM-1, P-selectin, and VCAM-1 expression are important in thrombotic complications by aPL antibodies and may provide novel targets for therapy in patients with APS </plain></SENT>
</text></document>